NADAC in April 2025
Ben LinkNADAC, Medicaid, Generic, Brand drugs, List prices, WAC, wholesalers, AMP-cap, Specialty, Focalin XR, Diclegis, Mavenclad, Xylocaine-MPF
FTC Part II: Investigations in Public Data for the FTC List of Meds
Ben LinkNADAC, Medicaid, Generic, Brand drugs, List prices, WAC, wholesalers, AMP-cap, Specialty, Focalin XR, Diclegis, Mavenclad, Xylocaine-MPF
MCuban v1
Ben LinkNADAC, Medicaid, Generic, Brand drugs, List prices, WAC, wholesalers, AMP-cap, Specialty, Focalin XR, Diclegis, Mavenclad, Xylocaine-MPF
Money from Sick People Part III: Why is U.S. drug pricing policy designed to exploit patients? (Copy)
Ben LinkBrand drugs, List prices, Rebates, WAC, Insulin, Lantus, PBM, Humalog, CVS, 340B, Medicaid, McKesson, pharmacy
How money from sick people works, Part II: The 340B story (Original)
Ben LinkBrand drugs, List prices, Rebates, WAC, Insulin, Lantus, PBM, Humalog, CVS, 340B, Medicaid, McKesson, pharmacy
Flash(ish) Finding: Drug Spending vs. Net Drug Spending vs. PMPM in Medicaid 2020
Ben LinkNADAC, Medicaid, Generic, Brand drugs, List prices, WAC, Rebates, Utilization, Ingrezza, Adcetris, Vascepa, Santyl, Methylphenidate, sevelamer, venlafaxine, ethosuximide, perphenazine, celecoxib, entecavir
The question on everyone’s mind: What is going on with midyear drug price increases?
46brooklyn Releases Two Dashboards to Assist with Drug Shortage Research (Copy)
